Stock listing
KRX:174900 AbClon, Inc. (앱클론) 주가
Follow AbClon, Inc. into a list and get an email when it puts out news.
Share price · KRX:174900
₩23,350 KRW -1,150 (-4.7%)
Close on Nov 20, 2026
- Day range
- ₩22,850 – ₩24,100 KRWNov 20, 2026
- Volume
- 93,384 sharesNov 20, 2026
- Market cap
- ₩465.9B KRWAt the close on Nov 20, 2026 · price × 19.95M shares outstanding
- 52-week range
- ₩15,800 – ₩95,800 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩4.23B KRWMedian day 170,512 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:174900 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩23,350 | -1,150 | -4.7% | ₩23,350 | ₩24,100 | ₩22,850 | 93,384 | |
| ₩24,500 | +350 | +1.4% | ₩24,200 | ₩26,450 | ₩23,750 | 286,317 | |
| ₩24,150 | +1,150 | +5.0% | ₩22,700 | ₩24,900 | ₩22,000 | 152,611 | |
| ₩23,000 | +50 | +0.2% | ₩23,100 | ₩24,200 | ₩22,450 | 169,927 | |
| ₩22,950 | +1,100 | +5.0% | ₩21,950 | ₩25,350 | ₩21,750 | 199,750 | |
| ₩21,850 | -750 | -3.3% | ₩22,400 | ₩23,450 | ₩21,800 | 118,838 | |
| ₩22,600 | +2,500 | +12.4% | ₩20,100 | ₩23,350 | ₩20,000 | 333,974 | |
| ₩20,100 | +2,860 | +16.6% | ₩17,800 | ₩20,600 | ₩17,500 | 204,043 | |
| ₩17,240 | +930 | +5.7% | ₩16,310 | ₩18,030 | ₩15,800 | 177,965 | |
| ₩16,310 | -2,020 | -11.0% | ₩16,850 | ₩17,210 | ₩16,230 | 219,692 | |
| ₩18,330 | +510 | +2.9% | ₩18,120 | ₩19,500 | ₩18,100 | 138,858 | |
| ₩17,820 | +570 | +3.3% | ₩17,250 | ₩17,860 | ₩16,410 | 151,777 | |
| ₩17,250 | -1,080 | -5.9% | ₩18,310 | ₩18,350 | ₩17,250 | 110,100 | |
| ₩18,330 | -140 | -0.8% | ₩18,320 | ₩19,000 | ₩18,150 | 67,613 | |
| ₩18,470 | -1,140 | -5.8% | ₩19,520 | ₩21,450 | ₩18,300 | 279,757 | |
| ₩19,610 | -1,490 | -7.1% | ₩21,000 | ₩21,050 | ₩19,120 | 294,395 | |
| ₩21,100 | 0 | 0.0% | ₩21,250 | ₩22,350 | ₩20,500 | 257,166 | |
| ₩21,100 | -250 | -1.2% | ₩21,750 | ₩22,950 | ₩20,900 | 123,447 | |
| ₩21,350 | -200 | -0.9% | ₩21,200 | ₩22,400 | ₩20,850 | 98,910 | |
| ₩21,550 | -1,400 | -6.1% | ₩22,400 | ₩22,750 | ₩20,800 | 175,873 | |
| ₩22,950 | -700 | -3.0% | ₩23,400 | ₩24,300 | ₩22,850 | 200,881 | |
| ₩23,650 | +1,100 | +4.9% | ₩23,000 | ₩24,600 | ₩22,900 | 180,816 | |
| ₩22,550 | -50 | -0.2% | ₩22,650 | ₩22,900 | ₩21,500 | 131,676 | |
| ₩22,600 | -1,200 | -5.0% | ₩23,400 | ₩23,800 | ₩22,300 | 147,984 | |
| ₩23,800 | +2,650 | +12.5% | ₩21,450 | ₩24,400 | ₩21,150 | 220,639 | |
| ₩21,150 | -2,250 | -9.6% | ₩22,450 | ₩23,000 | ₩20,700 | 260,224 | |
| ₩23,400 | -200 | -0.8% | ₩23,750 | ₩24,950 | ₩22,750 | 132,831 | |
| ₩23,600 | -1,000 | -4.1% | ₩24,350 | ₩24,400 | ₩22,500 | 187,476 | |
| ₩24,600 | -950 | -3.7% | ₩25,450 | ₩26,700 | ₩24,600 | 171,096 | |
| ₩25,550 | -1,350 | -5.0% | ₩26,500 | ₩26,600 | ₩25,050 | 186,983 | |
| ₩26,900 | -1,900 | -6.6% | ₩28,700 | ₩28,700 | ₩26,800 | 165,163 | |
| ₩28,800 | +900 | +3.2% | ₩28,000 | ₩29,500 | ₩27,300 | 246,927 | |
| ₩27,900 | +1,000 | +3.7% | ₩27,000 | ₩29,700 | ₩26,750 | 330,955 | |
| ₩26,900 | +4,550 | +20.4% | ₩22,350 | ₩28,100 | ₩21,900 | 536,798 | |
| ₩22,350 | +600 | +2.8% | ₩21,550 | ₩23,200 | ₩21,150 | 235,736 | |
| ₩21,750 | +2,440 | +12.6% | ₩19,350 | ₩22,550 | ₩19,110 | 357,272 | |
| ₩19,310 | -290 | -1.5% | ₩20,050 | ₩20,250 | ₩19,270 | 94,557 | |
| ₩19,600 | +380 | +2.0% | ₩19,420 | ₩20,150 | ₩19,400 | 59,853 | |
| ₩19,220 | -240 | -1.2% | ₩19,740 | ₩20,200 | ₩19,210 | 133,396 | |
| ₩19,460 | -100 | -0.5% | ₩19,570 | ₩19,860 | ₩19,130 | 117,367 | |
| ₩19,560 | -590 | -2.9% | ₩20,000 | ₩20,150 | ₩19,200 | 118,482 | |
| ₩20,150 | -100 | -0.5% | ₩20,350 | ₩20,900 | ₩20,050 | 68,726 | |
| ₩20,250 | -450 | -2.2% | ₩20,600 | ₩20,600 | ₩19,970 | 47,236 | |
| ₩20,700 | +450 | +2.2% | ₩20,450 | ₩21,800 | ₩20,000 | 119,188 | |
| ₩20,250 | -250 | -1.2% | ₩20,500 | ₩20,700 | ₩19,500 | 72,450 | |
| ₩20,500 | -350 | -1.7% | ₩20,350 | ₩20,800 | ₩19,900 | 80,476 | |
| ₩20,850 | -100 | -0.5% | ₩20,450 | ₩20,950 | ₩19,980 | 69,987 | |
| ₩20,950 | +500 | +2.4% | ₩20,450 | ₩21,450 | ₩20,000 | 103,599 | |
| ₩20,450 | -1,400 | -6.4% | ₩21,850 | ₩22,000 | ₩20,450 | 153,063 | |
| ₩21,850 | +250 | +1.2% | ₩21,750 | ₩22,300 | ₩21,100 | 96,217 | |
| ₩21,600 | +1,200 | +5.9% | ₩20,750 | ₩21,900 | ₩20,000 | 163,062 | |
| ₩20,400 | -1,900 | -8.5% | ₩22,550 | ₩22,650 | ₩20,200 | 209,116 | |
| ₩22,300 | -1,400 | -5.9% | ₩23,250 | ₩23,750 | ₩22,200 | 130,433 | |
| ₩23,700 | -900 | -3.7% | ₩24,700 | ₩24,700 | ₩23,200 | 114,025 | |
| ₩24,600 | -1,450 | -5.6% | ₩25,450 | ₩25,450 | ₩23,400 | 217,916 | |
| ₩26,050 | -1,600 | -5.8% | ₩27,650 | ₩27,650 | ₩25,050 | 222,845 | |
| ₩27,650 | -800 | -2.8% | ₩28,500 | ₩28,600 | ₩27,000 | 221,561 | |
| ₩28,450 | +150 | +0.5% | ₩28,800 | ₩30,000 | ₩27,900 | 195,761 | |
| ₩28,300 | -1,850 | -6.1% | ₩29,500 | ₩30,150 | ₩26,450 | 320,598 | |
| ₩30,150 | +2,600 | +9.4% | ₩28,200 | ₩30,800 | ₩27,700 | 347,389 | |
| ₩27,550 | -2,550 | -8.5% | ₩29,700 | ₩29,700 | ₩26,500 | 193,221 | |
| ₩30,100 | +350 | +1.2% | ₩31,700 | ₩32,200 | ₩28,450 | 261,766 |
Splits
1 split · KRX:174900 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- KRX:174900
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Apr 7, 2026
Abclon Wins 396 Million Won Order
Latest news
Abclon Wins 396 Million Won Order
Apr 7, 2026
Closed ₩53,500 (+5.1%) on Apr 8, 2026
Abclon Wins 778 Million Won Order
Mar 9, 2026
Closed ₩63,100 (-5.1%) on Mar 9, 2026
AbClon, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 2 in all · newest Apr 7, 2026 · oldest 2026
Valuation
EV/sales 80.9× against a median of 232×: 5th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩429.5B KRW
- P/E
- Loss
- EV/sales
- 80.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 8.8×
- Gross margin
- 12.7%
- Operating margin
- −336.4%
- Net margin
- −328.3%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| AbClon, Inc. · KRX:174900 | US$346.2M | US$319.2M | n/a | 80.9× | n/a | 8.8× | −328.3% | 0.0× | n/a |
| PureTech Health PLC · LSE:PRTC | US$364.6M | US$160.6M | n/a | 34.5× | n/a | 0.9× | n/a | 0.1× | n/a |
| Puma Biotechnology Inc · NASDAQ:PBYI | US$364.5M | US$255.9M | 15.3× | 1.1× | 5.8× | 2.5× | 10.3% | 0.0× | 0.88 |
| Lumosa Therapeutics Co Ltd · TPEX:6535 | US$362.4M | US$343.2M | n/a | 329× | n/a | 9.7× | n/a | 0.0× | n/a |
| Aspen Neuroscience, Inc. · NASDAQ:ASPE | US$361.2M | US$288.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Alector, Inc. · NASDAQ:ALEC | US$347.6M | US$208.9M | 8.4× | 1.2× | 4.9× | 3.0× | 23.9% | 0.0× | 1.72 |
| Gongwin Biopharm Holdings Co., Ltd. · TPEX:6617 | US$347.3M | US$296.6M | n/a | 232× | n/a | 4.9× | −389.6% | 0.0× | n/a |
| Onconic Therapeutics, Inc. · KRX:476060 | US$344.5M | US$298.0M | 19.1× | 4.9× | n/a | 5.4× | 29.5% | 0.0× | n/a |
| Lyell Immunopharma, Inc. · NASDAQ:LYEL | US$339.3M | US$196.5M | n/a | 13,099× | n/a | 1.8× | n/a | 0.2× | 1.51 |
| Avacta Group PLC · LSE:AVCT | US$338.1M | US$337.5M | n/a | 2,281× | n/a | 68.5× | n/a | 5.3× | n/a |
| Inovio Pharmaceuticals, Inc. · NASDAQ:INO | US$329.7M | US$7.56B | n/a | 25,303× | 3.4× | n/a | n/a | n/a | 0.70 |
| Median of the others | US$347.5M | US$292.7M | 15.3× | 232× | 4.9× | 4.0× | 17.1% | 0.0× | 1.20 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2020 | Feb 4, 2021 · Before open | −1.2% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 2.34B | 2.88B | 3.41B | 3.02B | 2.77B | 14.4B | 3.92B | 3.53B | 3.12B |
| Cost of revenue | 3.57B | 1.26B | 807.3M | 1.03B | 1.40B | 1.56B | 1.38B | 1.65B | 1.52B | 1.34B |
| Gross profit | 1.14B | 1.08B | 2.07B | 2.38B | 1.62B | 1.21B | 13.0B | 2.27B | 2.01B | 1.78B |
| Research and development | 14.4B | 13.4B | 10.7B | 8.69B | 9.63B | 5.86B | 3.88B | 2.37B | 1.72B | 1.99B |
| Selling, general and administrative | 1.42B | 3.02B | 2.74B | 2.22B | 2.05B | 1.76B | 5.84B | 1.82B | 1.80B | 1.35B |
| Operating income | -17.6B | -15.6B | -11.8B | -8.75B | -10.2B | -6.57B | 4.28B | -1.96B | -1.54B | -1.61B |
| Depreciation and amortization | 1.13B | 1.49B | 1.59B | 1.52B | 1.39B | 1.13B | 500.8M | 353.2M | 295.5M | 276.0M |
| EBITDA | -16.5B | -14.1B | -10.2B | -7.23B | -8.83B | -5.44B | 4.78B | -1.60B | -1.25B | -1.33B |
| Interest expense | 438.7M | 900.1M | 1.35B | 489.6M | 178.7M | 189.0M | 151.8M | 0 | 0 | 0 |
| Income before tax | -17.9B | -16.3B | -12.9B | -10.3B | -10.2B | -6.44B | 4.70B | -1.80B | -1.43B | -1.54B |
| Income tax | -1.10B | 2.14B | -953.5M | 57.4M | 57.1M | |||||
| Net income | -17.9B | -16.3B | -12.9B | -9.25B | -10.2B | -6.44B | 2.57B | -842.7M | -1.48B | -1.60B |
| Earnings per share, basic | -898.70 | -935.52 | -830.91 | -604.11 | -670.10 | -421.84 | 178.83 | -58.85 | -109.01 | -130.90 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 39.0B | 18.9B | 12.3B | 5.30B | 765.5M | 1.54B | 3.44B | 6.85B | 3.83B | 2.14B |
| Short-term investments | 6.00B | 3.00B | 5.24B | 18.8B | 9.50B | 18.0B | 25.0B | 13.7B | 13.3B | 9.50B |
| Receivables | 280.3M | 189.0M | 48.1M | 187.1M | 50.8M | 132.0M | 1.80B | 1.10B | 291.3M | 609.6M |
| Inventory | 186.6M | 7.74M | 2.19M | 9.99M | 7.80M | 16.7M | 32.7M | 18.0M | 18.2M | 2.43M |
| Current assets | 46.0B | 23.2B | 19.3B | 25.0B | 11.9B | 21.5B | 31.1B | 22.2B | 17.6B | 12.5B |
| Property, plant and equipment | 24.1B | 25.2B | 26.9B | 17.1B | 17.9B | 15.2B | 5.09B | 3.03B | 3.24B | |
| Total assets | 70.7B | 48.2B | 45.4B | 54.1B | 29.8B | 40.1B | 47.0B | 28.7B | 20.9B | 16.0B |
| Accounts payable | 6.96M | 20.1M | 234.7M | 137.9M | 112.2M | 213.8M | 152.6M | 185.8M | 135.9M | 141.9M |
| Current liabilities | 9.35B | 18.1B | 17.6B | 8.75B | 10.0B | 4.55B | 5.56B | 9.17B | 2.80B | 1.40B |
| Long-term debt | 0 | 4.56B | 0 | 5.00B | 5.00B | 0 | 0 | 2.00B | ||
| Total debt | 5.09B | 5.01B | 2.00B | |||||||
| Total liabilities | 10.3B | 18.8B | 18.2B | 17.5B | 10.5B | 10.8B | 11.6B | 10.0B | 3.47B | 4.03B |
| Shareholders' equity | 60.4B | 29.4B | 27.2B | 36.6B | 19.4B | 29.3B | 35.4B | 18.7B | 17.4B | 12.0B |
| Shares outstanding | 19.9M | 17.4M | 15.5M | 15.3M | 15.3M | 15.3M | 14.4M | 14.3M | 13.6M | 12.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -13.8B | -14.4B | -9.48B | -7.49B | -8.64B | -5.65B | -449.9M | 3.71B | -1.11B | -204.9M |
| Capital spending | -617.6M | -167.5M | -49.8M | -75.6M | -505.4M | -3.44B | -10.6B | -2.36B | -63.7M | -242.2M |
| Free cash flow | -14.4B | -14.6B | -9.53B | -7.58B | -9.17B | -9.09B | -16.1B | 1.35B | -1.18B | -447.1M |
| Cash from investing | 2.07B | 13.6B | -9.46B | 7.99B | 3.75B | -22.1B | -2.89B | -3.87B | 257.8M | |
| Cash from financing | 18.8B | 2.89B | 21.5B | -116.8M | -8.96M | 19.1B | 2.29B | 6.69B | 6.69B | |
| Share buybacks | 17.0M | 3.08B | 12.1B | 0 | 100.0M | 14.1B | 2.29B | 6.69B | 0 | |
| Change in cash | 20.1B | 6.61B | 6.96B | 4.53B | -773.6M | -1.90B | -3.48B | 3.08B | 1.69B | -18.6M |
Cap table
Built by 6ix from AbClon, Inc.’s releases
- Common shares
- 19,952,129
- Fully diluted
- 19,952,129
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 19,952,129 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 19,952,129 |
Log in to ask 6ix AI your own questions about AbClon, Inc.